5-Methyl-2-Pyrazinecarboxylic Acidum CAS 5521-55-1 Puritas >99.0% (HPLC)

Description:

Nomen: 5-Methyl-2-Pyrazinecarboxylic Acidum

Synonyma: 5-Methylpyrazine-2-acidi carboxylicum

CAS: 5521-55-1

Puritas: >99.0% (HPLC)

Aspectus: Off-White Crystallized pulveris

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 5-Methyl-2-Pyrazinecarboxylic Acid (CAS: 5521-55-1) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	5-Methyl-2-Pyrazinecarboxylic Acidum
Synonyma	5-Methylpyrazine-2-Carboxylic Acidum
CAS Number	5521-55-1
CATTUS Number	RF-PI2146
Stock Status	In Stock, Productio Capacity 20 Tons/mense
Formulae hypotheticae	C6H6N2O2
M. Pondus	138.12
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Off-White Crystallized pulveris
Puritas / Analysis Methodus	>99.0% (HPLC)
Liquescens punctum	164.0~168.0℃
Aqua (auctore Karl Fischer)	<0.50%
Una immunditia	<0.50%
Totalis immunditias	<1.00%
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical Medium;Acipimox medius

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

5-Methyl-2-Pyrazinecarboxylicum acidum (CAS: 5521-55-1) est medium pharmaceuticum magni, quod maxime ponitur pro intermedio Acipimox.Acipimox est potentem diu agens acidum antilipolyticum nicotinicum (NA) analogum.Sicut acidum nicotinicum, acipimox efficaciter demittit lipidas, at acido nicotinico dissimilis, acipimox diutius agens est, ideoque multo minus proclivius ad liberum pingue acidum repercussu producendum.Acipimox commendatur ut agente lipido-demisso ad hyperlipidemiam in patientibus tractandis cum diabete mellito noninsulino dependens.Acipimox est agens hypolipidemicum ad acidum nicotinicum pronuntiatum, actio antilipolytica diuturna.Praeter lipidorum demissionem activitatem, beneficam elevationem anti-atherogenicae altitudinis densitatis lipoprotein subfractionis producit, HDL2.